Concepedia

Jiayao Ni

JN

Statistics

Publications

1

Citations

34

H-Index

1

Active since

2024

Affiliations

Nanjing University(Current)

Jiayao Ni is an author at Nanjing University specializing in pancreatic cancer, pharmacology, and gemcitabine-based therapy.

Publications per year

2024–2024

1

Publications

1

First-line penpulimab (an anti-PD1 antibody) and anlotinib (an angiogenesis inhibitor) with nab-paclitaxel/gemcitabine (PAAG) in metastatic pancreatic cancer: a prospective, multicentre, biomolecular exploratory, phase II trial

Huizi Sha, Fan Tong, Jiayao Ni et al. · Signal Transduction and Targeted Therapy · 2024 · 34 citations · Full text

Medicine, Oncology, Pharmacology +16

1–1 of 1